Business Context and Reporting Period
Company: HALOZYME THERAPEUTICS, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: June 30, 2017
Event: Entry into Material Definitive Agreements (Lease Amendments)
On June 30, 2017, Halozyme Therapeutics, Inc. and its subsidiary, Halozyme, Inc., entered into three lease amendments for office and research facilities located in San Diego, California. These amendments extend the company's tenancy at three specific addresses for an additional five-year term.
Key Financial Metrics and Terms
This filing details future rental obligations rather than historical financial performance. The following monthly base rent schedules apply to the extended lease terms:
11388 Sorrento Valley Road (27,575 sq. ft.)
| Period | Monthly Base Rent |
|---|---|
| Jan 15, 2018 - Jan 14, 2019 | $75,831.25 |
| Jan 15, 2019 - Jan 14, 2020 | $78,037.25 |
| Jan 15, 2020 - Jan 14, 2021 | $80,243.25 |
| Jan 15, 2021 - Jan 14, 2022 | $82,725.00 |
| Jan 15, 2022 - Jan 14, 2023 | $85,206.75 |
11404/11408 Sorrento Valley Road (30,371 sq. ft.)
| Period | Monthly Base Rent |
|---|---|
| Jan 15, 2018 - Jan 14, 2019 | $83,520.25 |
| Jan 15, 2019 - Jan 14, 2020 | $85,949.93 |
| Jan 15, 2020 - Jan 14, 2021 | $88,379.61 |
| Jan 15, 2021 - Jan 14, 2022 | $91,113.00 |
| Jan 15, 2022 - Jan 14, 2023 | $93,846.39 |
11436 Sorrento Valley Road (18,000 sq. ft.)
Note: This lease features variable monthly rent with specific reductions in February of each year.
| Period | Monthly Base Rent |
|---|---|
| Feb 1, 2018 - Jan 31, 2019 | $27,900.00 (Feb 2019: $14,369.00) |
| Mar 1, 2019 - Jan 31, 2020 | $28,737.00 (Feb 2020: $14,800.00) |
| Mar 1, 2020 - Jan 31, 2021 | $29,599.00 (Feb 2021: $15,244.00) |
| Mar 1, 2021 - Jan 31, 2022 | $30,487.00 (Feb 2022: $15,701.00) |
| Mar 1, 2022 - Jan 31, 2023 | $31,402.00 |
Material Changes and Contractual Terms
- Extension Duration: All three amendments extend the company's tenancy for an additional five years.
- Commencement Dates:
- 11388 and 11404/11408 leases commence on January 15, 2018.
- 11436 lease commences on February 1, 2018.
- Expiration Dates:
- 11388 and 11404/11408 leases expire on January 14, 2023.
- 11436 lease expires on January 31, 2023.
- Termination Rights: All amendments include an early termination option in favor of the Company.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, revenue outlook, or management commentary regarding future earnings. The primary risk disclosed is the commitment to future fixed operating costs (rent) for the extended periods. The filing explicitly states that the summary of terms is qualified in its entirety by the full text of the lease amendments attached as exhibits.
Investor Verification Checklist
- Verify the total aggregate annual rent obligation for fiscal years 2018 through 2023 based on the provided monthly schedules.
- Review the full text of Exhibits 10.1, 10.2, and 10.3 to understand specific clauses regarding early termination penalties, operating expense pass-throughs, and maintenance responsibilities.
- Confirm the company's current cash position and liquidity to ensure it can meet the increased or sustained rental obligations starting in early 2018.
- Assess whether the early termination options provide sufficient flexibility given the company's current pipeline and capital burn rate.